Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy-Reference-Cited by-同舟云学术

Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy

Published:2005-11 Issue:11 Volume:16 Page:1772-1777
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Burstein H.J.,Lieberman G.,Slamon D.J.,Winer E.P.,Klein P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/11/1772/302970/mdi371.pdf

Reference27 articles.

1. Winer EP. CNS metastases in breast cancer;Lin;J Clin Oncol,2004

2. The natural history of breast cancer patients with brain metastases;DiStefano;Cancer,1979

3. Brain metastases from breast cancer: clinical course;Sparrow;prognosis and influence of treatment. Clin Oncol,1981

4. Brain metastases in breast cancer; natural history;Boogerd;prognostic factors and outcome. J Neurooncol,1993

5. Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer;Stewart;Eur J Cancer,1981

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging;PLOS ONE;2024-05-03

2. The age and growth information of a ctenoid scale fossil from the Upper Cretaceous Nenjiang Formation in Songliao Basin, China;PLOS ONE;2024-05-03

3. Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits;Frontiers in Oncology;2023-06-16

4. Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis;Frontiers in Oncology;2023-04-05

5. Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis;Neuro-Oncology;2022-07-22